60 related articles for article (PubMed ID: 15341951)
1. The identification and optimization of 2,4-diketobutyric acids as flap endonuclease 1 inhibitors.
Tumey LN; Huck B; Gleason E; Wang J; Silver D; Brunden K; Boozer S; Rundlett S; Sherf B; Murphy S; Bailey A; Dent T; Leventhal C; Harrington J; Bennani YL
Bioorg Med Chem Lett; 2004 Oct; 14(19):4915-8. PubMed ID: 15341951
[TBL] [Abstract][Full Text] [Related]
2. The identification and optimization of a N-hydroxy urea series of flap endonuclease 1 inhibitors.
Tumey LN; Bom D; Huck B; Gleason E; Wang J; Silver D; Brunden K; Boozer S; Rundlett S; Sherf B; Murphy S; Dent T; Leventhal C; Bailey A; Harrington J; Bennani YL
Bioorg Med Chem Lett; 2005 Jan; 15(2):277-81. PubMed ID: 15603939
[TBL] [Abstract][Full Text] [Related]
3. Development of a high-throughput fluorescence polarization DNA cleavage assay for the identification of FEN1 inhibitors.
McWhirter C; Tonge M; Plant H; Hardern I; Nissink W; Durant ST
J Biomol Screen; 2013 Jun; 18(5):567-75. PubMed ID: 23427045
[TBL] [Abstract][Full Text] [Related]
4. Amino acid Asp181 of 5'-flap endonuclease 1 is a useful target for chemotherapeutic development.
Panda H; Jaiswal AS; Corsino PE; Armas ML; Law BK; Narayan S
Biochemistry; 2009 Oct; 48(42):9952-8. PubMed ID: 19769410
[TBL] [Abstract][Full Text] [Related]
5. Identification of human flap endonuclease 1 (FEN1) inhibitors using a machine learning based consensus virtual screening.
Deshmukh AL; Chandra S; Singh DK; Siddiqi MI; Banerjee D
Mol Biosyst; 2017 Jul; 13(8):1630-1639. PubMed ID: 28685785
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of BACE1 inhibitors containing a novel norstatine derivative (2R,3R)-3-amino-2-hydroxy-4-(phenylthio)butyric acid.
Ziora Z; Kasai S; Hidaka K; Nagamine A; Kimura T; Hayashi Y; Kiso Y
Bioorg Med Chem Lett; 2007 Mar; 17(6):1629-33. PubMed ID: 17251016
[TBL] [Abstract][Full Text] [Related]
7. Targeting DNA Flap Endonuclease 1 to Impede Breast Cancer Progression.
He L; Zhang Y; Sun H; Jiang F; Yang H; Wu H; Zhou T; Hu S; Kathera CS; Wang X; Chen H; Li H; Shen B; Zhu Y; Guo Z
EBioMedicine; 2016 Dec; 14():32-43. PubMed ID: 27852524
[TBL] [Abstract][Full Text] [Related]
8. Suppression of base excision repair reactions by apoptotic 24kDa-fragment of poly(ADP-ribose) polymerase 1 in bovine testis nuclear extract.
Sukhanova M; Khodyreva S; Lavrik O
DNA Repair (Amst); 2007 May; 6(5):615-25. PubMed ID: 17236819
[TBL] [Abstract][Full Text] [Related]
9. Wheat (Triticum vulgare) chloroplast nuclease ChSI exhibits 5' flap structure-specific endonuclease activity.
Przykorska A; Solecka K; Olszak K; Keith G; Nawrot B; Kuligowska E
Biochemistry; 2004 Sep; 43(35):11283-94. PubMed ID: 15366938
[TBL] [Abstract][Full Text] [Related]
10. The two DNA clamps Rad9/Rad1/Hus1 complex and proliferating cell nuclear antigen differentially regulate flap endonuclease 1 activity.
Friedrich-Heineken E; Toueille M; Tännler B; Bürki C; Ferrari E; Hottiger MO; Hübscher U
J Mol Biol; 2005 Nov; 353(5):980-9. PubMed ID: 16216273
[TBL] [Abstract][Full Text] [Related]
11. Investigation of human flap structure-specific endonuclease 1 (FEN1) activity on primer-template models and exploration of a substrate-based FEN1 inhibitor.
Ba S; Zhang H; Lee JY; Wu H; Ye R; Huang D; Li T
Bioorg Med Chem; 2016 May; 24(9):1988-92. PubMed ID: 27020684
[TBL] [Abstract][Full Text] [Related]
12. Complementary non-radioactive assays for investigation of human flap endonuclease 1 activity.
Dorjsuren D; Kim D; Maloney DJ; Wilson DM; Simeonov A
Nucleic Acids Res; 2011 Jan; 39(2):e11. PubMed ID: 21062821
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of novel metalloproteinase inhibitors.
Nakatani S; Ikura M; Yamamoto S; Nishita Y; Itadani S; Habashita H; Sugiura T; Ogawa K; Ohno H; Takahashi K; Nakai H; Toda M
Bioorg Med Chem; 2006 Aug; 14(15):5402-22. PubMed ID: 16621578
[TBL] [Abstract][Full Text] [Related]
14. Cellularly active N-hydroxyurea FEN1 inhibitors block substrate entry to the active site.
Exell JC; Thompson MJ; Finger LD; Shaw SJ; Debreczeni J; Ward TA; McWhirter C; Siöberg CL; Martinez Molina D; Abbott WM; Jones CD; Nissink JW; Durant ST; Grasby JA
Nat Chem Biol; 2016 Oct; 12(10):815-21. PubMed ID: 27526030
[TBL] [Abstract][Full Text] [Related]
15. A refined pharmacophore model for HIV-1 integrase inhibitors: Optimization of potency in the 1H-benzylindole series.
De Luca L; Barreca ML; Ferro S; Iraci N; Michiels M; Christ F; Debyser Z; Witvrouw M; Chimirri A
Bioorg Med Chem Lett; 2008 May; 18(9):2891-5. PubMed ID: 18417342
[TBL] [Abstract][Full Text] [Related]
16. QSAR and Docking Studies of N-hydroxy Urea Derivatives as Flap Endonuclease-1 Inhibitors.
Wadhwa P; Jain P; Jadhav HR
Curr Comput Aided Drug Des; 2015; 11(4):346-52. PubMed ID: 26603927
[TBL] [Abstract][Full Text] [Related]
17. Discovery of Myricetin as a Potent Inhibitor of Human Flap Endonuclease 1, Which Potentially Can Be Used as Sensitizing Agent against HT-29 Human Colon Cancer Cells.
Ma L; Cao X; Wang H; Lu K; Wang Y; Tu C; Dai Y; Meng Y; Li Y; Yu P; Man S; Diao A
J Agric Food Chem; 2019 Feb; 67(6):1656-1665. PubMed ID: 30694659
[TBL] [Abstract][Full Text] [Related]
18. Pharmacophore guided discovery of small-molecule human apurinic/apyrimidinic endonuclease 1 inhibitors.
Zawahir Z; Dayam R; Deng J; Pereira C; Neamati N
J Med Chem; 2009 Jan; 52(1):20-32. PubMed ID: 19072053
[TBL] [Abstract][Full Text] [Related]
19. Fen1 does not control somatic hypermutability of the (CTG)(n)*(CAG)(n) repeat in a knock-in mouse model for DM1.
van den Broek WJ; Nelen MR; van der Heijden GW; Wansink DG; Wieringa B
FEBS Lett; 2006 Oct; 580(22):5208-14. PubMed ID: 16978612
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of immunosuppressive agent DZ2002 and its stereoisomers.
Zhang YM; Ding Y; Tang W; Luo W; Gu M; Lu W; Tang J; Zuo JP; Nan FJ
Bioorg Med Chem; 2008 Oct; 16(20):9212-6. PubMed ID: 18815049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
